Security Insights
Latest threat analysis, industry news, and security best practices from our expert team.
Metasploit 2026 Update: New Kerberos & Certificate Tracing — Detection and Hardening
Introduction In the June 2026 Metasploit Weekly Update, Rapid7 introduced significant quality-of-life improvements for operators: KerberosTi...
Labcorp $35M Settlement: Third-Party Risk and Web Compromise Defense
Introduction The recent $35 million settlement agreed to by Labcorp resolves litigation stemming from the 2018 American Medical Collection A...
CVE-2026-35273: Oracle PeopleTools KEV Addition — Active Exploitation and Hardening Guide
CISA KEV Alert: Oracle PeopleSoft Missing Authentication Vulnerability (CVE-2026-35273) Introduction On June 12, 2026, the Cybersecurity and...
Agentjacking: Defending AI Coding Agents from Sentry-Based Code Injection
Introduction In the rapidly evolving landscape of 2026, AI coding agents have shifted from experimental tools to essential components of the...
The Gentlemen RaaS (Storm-2697) & AI Supply Chain (AMOS Stealer): OTX Pulse Analysis
Threat Summary Recent OTX pulses highlight a dual-threat landscape characterized by a sophisticated, high-volume Ransomware-as-a-Service (Ra...
SilabRAT MaaS & Storm-3075 AI Phishing: OTX Pulse Analysis — Enterprise Detection Pack
SilabRAT MaaS & Storm-3075 AI Phishing: OTX Pulse Analysis — Enterprise Detection Pack Threat Summary Recent intelligence from OTX highlight...
Storm-3075, SilabRAT, and AI-Themed Infostealers: OTX Pulse Analysis — Enterprise Detection Pack
Storm-3075, SilabRAT, and AI-Themed Infostealers: OTX Pulse Analysis Threat Summary Recent OTX pulses reveal a coordinated surge in credenti...
QILIN Ransomware Gang: 19 New Victims Posted — Critical Firewall & RaaS Activity Surge
QILIN Ransomware Gang: 19 New Victims Posted — Critical Firewall & RaaS Activity Surge Threat Actor Profile — QILIN Aliases: Qilin, Agenda. ...
Novo Nordisk Clinical Trial Data Breach: Defending R&D and EPHI
Novo Nordisk Clinical Trial Data Breach: Defending R&D and EPHI Introduction Novo Nordisk, a global pharmaceutical leader, recently disclose...